Watch for Dosing Confusion with Ceftolozane/Tazobactam

Please see the FDA safety warning (May 2015) concerning dose confusion/medication errors associated with Zerbaxa

Reps will be promoting a new IV anti-infective, ceftolozane/tazobactam (Zerbaxa).

Ceftolozane/tazobactam is approved for complicated UTIs (cUTIs) and intra-abdominal infections (cIAIs) in adults...and higher doses are still being studied for ventilator-associated pneumonia.

Think of it as primarily covering gram-negative bacteria...including Pseudomonas and ESBL-producing Enterobacteriaceae.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote